Literature DB >> 21132550

The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China.

Yu-Qiong Zou1, Ya-Song Li, Xiao-Nan Ding, Zhen-Hua Ying.   

Abstract

The objective of this study is to describe the interstitial lung disease (ILD) in rheumatoid arthritis (RA) patients of China, and to study clinical significance of high-resolution computed tomography (HRCT) in evaluation and treatment. One hundred and ten Chinese patients (79 women and 31 man) diagnosed with RA between December 2008 to November 2009 were analyzed. According to the HRCT, 47 (42.73%) RA patients were diagnosed as ILD. Old age, smoking and pulmonary rales were closely related to ILD (P < 0.05). The main appearances of ILD were ground-glass (39.09%), honeycombing (4.55%), reticular patterns and consolidation (1.82%). Patients with reticular patterns and honeycombing were more likely to show the respiratory symptoms. It was also common to find other abnormal changes, such as fiber cord shadow (22.73%), lung markings fuzzy disorder (30%), pulmonary nodules (11.82%), emphysema (9.09%), bronchiectasis (3.64%), subpleural nodules (11.82%) and pleural thickening (24.55%). In treatment, honeycombing and subpleural nodules were more common in patients with methotrexate (MTX) and/or leflunomide treatment than without (P < 0.05). Other abnormal changes were no statistical significance (P > 0.05). Pulmonary involvement is common in RA patients, and it is suggested that HRCT could be a sensitive and useful way in evaluating the lung of RA patients.

Entities:  

Mesh:

Year:  2010        PMID: 21132550     DOI: 10.1007/s00296-010-1665-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group.

Authors:  G S Alarcón; J M Kremer; M Macaluso; M E Weinblatt; G W Cannon; W R Palmer; E W St Clair; J S Sundy; R W Alexander; G J Smith; C A Axiotis
Journal:  Ann Intern Med       Date:  1997-09-01       Impact factor: 25.391

Review 2.  Drug-induced and iatrogenic infiltrative lung disease.

Authors:  Philippe Camus; Philippe Bonniaud; Annlyse Fanton; Clio Camus; Nicolas Baudaun; Pascal Foucher
Journal:  Clin Chest Med       Date:  2004-09       Impact factor: 2.878

3.  Japan deaths spark concerns over arthritis drug.

Authors:  Justin McCurry
Journal:  Lancet       Date:  2004-02-07       Impact factor: 79.321

4.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.

Authors:  Carl Turesson; W Michael O'Fallon; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

5.  Pulmonary involvement in rheumatoid arthritis.

Authors:  Ayhan Bilgici; H Ulusoy; O Kuru; C Celenk; M Unsal; M Danaci
Journal:  Rheumatol Int       Date:  2004-07-28       Impact factor: 2.631

6.  High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis.

Authors:  W U Hassan; N P Keaney; C D Holland; C A Kelly
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

7.  Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis.

Authors:  G W Cannon; J R Ward; D O Clegg; C O Samuelson; T M Abbott
Journal:  Arthritis Rheum       Date:  1983-10

8.  Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.

Authors:  Yasuyuki Kamata; Hiroyuki Nara; Takeshi Kamimura; Kengo Haneda; Masahiro Iwamoto; Junichi Masuyama; Hitoaki Okazaki; Seiji Minota
Journal:  Intern Med       Date:  2004-12       Impact factor: 1.271

9.  Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis.

Authors:  J Biederer; A Schnabel; C Muhle; W L Gross; M Heller; M Reuter
Journal:  Eur Radiol       Date:  2003-10-14       Impact factor: 5.315

10.  High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease.

Authors:  J McDonagh; M Greaves; A R Wright; C Heycock; J P Owen; C Kelly
Journal:  Br J Rheumatol       Date:  1994-02
View more
  12 in total

1.  [Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease].

Authors:  H Zhu; L J Zhao; Y Zhou; Y Chen
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

Review 2.  Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms.

Authors:  Francisco Paulin; Tracy J Doyle; Elaine A Fletcher; Dana P Ascherman; Ivan O Rosas
Journal:  Rev Invest Clin       Date:  2015 Sep-Oct       Impact factor: 1.451

Review 3.  Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.

Authors:  Robert W Hallowell; Maureen R Horton
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

4.  Interstitial lung disease in rheumatoid arthritis in the era of biologics.

Authors:  A Picchianti Diamanti; V Germano; E Bizzi; B Laganà; A Migliore
Journal:  Pulm Med       Date:  2011-12-20

5.  A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients.

Authors:  Jun-Xiang Wang; Chuan-Guo Du
Journal:  Med Sci Monit       Date:  2015-03-07

6.  Expression of CCR3, SOX5 and LC3 in patients with elderly onset rheumatoid arthritis and the clinical significance.

Authors:  Jing Wang; Qing Zhao
Journal:  Exp Ther Med       Date:  2017-08-18       Impact factor: 2.447

7.  Modeling using clinical examination indicators predicts interstitial lung disease among patients with rheumatoid arthritis.

Authors:  Yao Wang; Wuqi Song; Jing Wu; Zhangming Li; Fengyun Mu; Yang Li; He Huang; Wenliang Zhu; Fengmin Zhang
Journal:  PeerJ       Date:  2017-02-21       Impact factor: 2.984

8.  Interstitial Lung Disease and its Associations in Rheumatoid Arthritis: Data from a District General Hospital in Sri Lanka.

Authors:  Geetha Wickrematilake
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-06-30

9.  Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease.

Authors:  Juan Chen; YongHong Shi; XiaoPing Wang; Heqing Huang; Dana Ascherman
Journal:  Clin Dev Immunol       Date:  2013-07-31

10.  Rheumatoid arthritis-associated lung disease in black Africans: Descriptive study of 28 cases in Lomé.

Authors:  A G Gbadamassi; K S Adjoh; A N E Fianyo; T A S Adambounou; A K Aziagbe; P Efalou
Journal:  Afr J Thorac Crit Care Med       Date:  2020-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.